Gliclazide and Metformin Tablet
Generic Name |
Gliclazide and Metformin |
---|---|
Strength |
60 mg + 500 mg, 80 mg + 500 mg |
Form |
Tablet |
Packaging |
1 X 10 Tablets |
Therapeutic use |
Anti Diabetic |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Voglibose and Metformin Tablet | 0.2 mg + 1000 mg, 0.2 mg + 500 mg, 0.3mg + 1000 mg, 0.3 mg + 500 mg | Anti Diabetic | |
Glimepiride, Pioglitazone and Metformin Tablet | 2 mg + 500 mg + 7.5 mg, 1 mg + 500 mg + 15mg, 2 mg + 500 mg + 15 mg | Anti Diabetic | |
Glimepiride, Metformin and Voglibose Tablet | 1 mg + 500 mg + 0.2 mg, 2 mg + 500 mg + 0.2 mg | Anti Diabetic | |
Gliclazide Tablet | 30 mg, 60 mg, 80 mg | Anti Diabetic | |
Gliclazide and Metformin Tablet | 60 mg + 500 mg, 80 mg + 500 mg | Anti Diabetic | |
Glibenclamide and Metformin Tablet | 2.5 mg + 500 mg, 5 mg + 500 mg | Anti Diabetic | |
Empagliflozin and Metformin Tablet | 12.5 mg + 500 mg | Anti Diabetic | |
Pioglitazone and Metformin HCL Tablet | 15 mg + 500 mg | Anti Diabetic, Type 2 diabetes | |
Sitagliptin and Metformin Tablet | 50 mg + 1000 mg, 50 mg + 500 mg | Anti Diabetic, Type 2 diabetes |
Product Description For Gliclazide and Metformin Tablet
products details and uses
Gliclazide and Metformin Tablet Supplier | Manufacturer & Global Exporter
Gliclazide and Metformin Tablet Supplier, as a trusted we ensure our products are manufactured under strict WHO-GMP and ISO-certified guidelines. With global distribution experience, we offer reliable formulations that meet the highest standards of efficacy, safety, and affordability for patients across diverse healthcare markets.
Gliclazide and Metformin Tablet is a well-recognized oral anti-diabetic combination medication widely prescribed for the treatment of type 2 diabetes mellitus. This dual therapy integrates the power of Gliclazide, a sulfonylurea that stimulates insulin secretion, with Metformin, a biguanide that reduces hepatic glucose production and improves insulin sensitivity. Together, they provide comprehensive control of blood sugar levels in patients who do not achieve adequate glycemic control with diet, exercise, or monotherapy.
About Gliclazide and Metformin Tablet
This fixed-dose combination is designed to provide superior glycemic management. Gliclazide works by enhancing insulin secretion from the pancreatic beta cells, while Metformin improves insulin sensitivity and lowers glucose production by the liver. As an experienced Gliclazide and Metformin Tablet Supplier, we produce multiple strengths and customized pack sizes to meet the needs of hospitals, pharmacies, and global distributors.
Key Benefits and Uses
-
Provides effective blood sugar control in type 2 diabetes.
-
Reduces the risk of long-term diabetic complications.
-
Combines two mechanisms of action for better results.
-
Convenient once or twice daily dosing for patient compliance.
-
Can be prescribed when lifestyle modifications and single-drug therapy are insufficient.
By being a reliable Gliclazide and Metformin Tablet Supplier, we make sure that healthcare professionals have consistent access to this important medication worldwide.
Dosage and Administration
The dosage of Gliclazide and Metformin Tablet should always be individualized according to patient needs and prescribed by a healthcare professional. It is typically taken with meals to reduce gastrointestinal discomfort and minimize the risk of hypoglycemia. Being a trusted Gliclazide and Metformin Tablet Supplier, we provide detailed dosage instructions and labeling that complies with regulatory guidelines in India and international markets.
Precautions
As a responsible Gliclazide and Metformin Tablet Supplier, we recommend observing the following precautions for patient safety:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Should be avoided in patients with severe kidney or liver impairment.
-
Regular blood sugar monitoring is necessary during treatment.
-
Alcohol consumption should be avoided to reduce the risk of hypoglycemia and lactic acidosis.
-
Pregnant and breastfeeding women should only use under strict medical supervision.
Possible Side Effects
Although generally well-tolerated, some patients may experience mild to moderate side effects, such as:
-
Hypoglycemia (low blood sugar episodes).
-
Nausea, vomiting, or diarrhea.
-
Abdominal discomfort or metallic taste.
-
Rarely, lactic acidosis due to Metformin.
-
Weight gain in some patients due to Gliclazide.
As an established Gliclazide and Metformin Tablet Supplier, we maintain transparency and ensure our clients are informed about the potential side effects to promote safer use of the medication.
Why Choose Us?
-
WHO-GMP and ISO-certified production facilities.
-
Recognized as a reliable Gliclazide and Metformin Tablet Supplier with a wide global distribution network.
-
Expertise in third-party manufacturing and bulk supply.
-
Flexible packaging solutions to meet international standards.
-
Competitive pricing without compromising on quality.
As a reputed Gliclazide and Metformin Tablet Supplier, our mission is to support healthcare professionals, institutions, and distributors by delivering premium quality anti-diabetic medicines that enhance patient health outcomes.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Gliclazide and Metformin Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.